Our Opinion

Reunion Neuroscience Inc. is on the Cruelty-Free Investing usage of animals list because they undertake pre-clinical studies on animals to examine the safety profile of their medications.

Company Description

Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company, engages in developing new molecules to treat mental health conditions in North America. The company’s lead asset, RE104, a proprietary, novel, and serotonergic psychedelic compound. It is also developing the RE200 series, which includes preclinical compounds with enhanced receptor selectivity to address additional therapeutic applications. The company was formerly known as Field Trip Health Ltd. Reunion Neuroscience Inc. was founded in 2008 and is headquartered in Toronto, Canada.

Company Website: https://reunionneuro.com